Sort   by:  
 Page size 
UnknownPooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3074275 | biostudies-literature
UnknownMutation and association analysis of GEN1 in breast cancer susceptibility.
Not available
S-EPMC3632835 | biostudies-literature
UnknownAssociation of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3077716 | biostudies-literature
UnknownGermline mutations in RAD51D confer susceptibility to ovarian cancer.
Not available
S-EPMC4845885 | biostudies-literature
UnknownCommon variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC2893806 | biostudies-literature
UnknownCommon variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC2782243 | biostudies-literature
UnknownGenetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3107565 | biostudies-literature
UnknownCommon breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Not available
S-EPMC2999830 | biostudies-literature
UnknownBreast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2.
Not available
S-EPMC3387216 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
Sort   by:  
 Page size